AnteoTech's 2021 Sales Performance, page-19

I agree with your "Bradbury" analogy

I think we will ultimately sell our $30 Mill of tests a year , with each our distributors picking up the small orders x 10 , the orders the "big boys" can't be bothered with - this will justify a market cap and share price much higher than we are today

I think many of our esteemed posters are frustrated because they see what we could have become under less conservative stewardship

I understand financial constraints but post capital raise they have no excuse - with the right moves our little company could have been anything

I have stated in the past I can forgive mistakes as long as we learn from them - currently nothing is convincing me we have learnt a thing.

The question for the AGM is , if we have the same people running the show , why would we expect the outcomes to be any different for 2022 ?